Martin Shkreli’s Conviction Is Upheld by U.S. Appeals Court
- ‘Pharma Bro’ denied he’d ever intended to defraud investors
- Appeal was rejected just weeks after attorneys made arguments
This article is for subscribers only.
Martin Shkreli’s fraud conviction was upheld by a federal appeals court in New York, which rejected his claim that jurors got erroneous instructions from the trial judge.
Shkreli was convicted two years ago of lying to investors in two of his hedge funds and also manipulating shares of Retrophin Inc., a biotech company he founded. He was sentenced to seven years and sent to a low-security prison camp.